|
WO2021081515A2
|
|
Compositions and methods for the treatment of human immunodeficiency virus
|
|
WO2021050612A1
|
|
Compositions and methods for the treatment of respiratory syncytial virus
|
|
WO2021046549A1
|
|
Compositions and methods for the treatment of viral infections
|
|
WO2021035177A2
|
|
Variant fc domains and uses thereof
|
|
WO2020252393A1
|
|
Compositions and methods for the treatment of human immunodeficiency virus
|
|
WO2020252396A1
|
|
Compositions and methods for the treatment of respiratory syncytial virus
|
|
WO2020086931A1
|
|
Polymorph of echinocandin antifungal agent
|
|
AU2019336230A1
|
|
Compositions and methods for the treatment of viral infections
|
|
WO2020014501A1
|
|
Compositions and methods for the treatment of bacterial infections
|
|
WO2020014469A1
|
|
Compositions and methods for the treatment of bacterial infectons
|
|
AU2019287621A1
|
|
Synthesis of echinocandin antifungal agent
|
|
WO2019126353A2
|
|
Compositions and methods for the treatment of bacterial infections
|
|
WO2019126341A2
|
|
Compositions and methods for the treatment of bacterial infections
|
|
CN111050798A
|
|
Compositions and methods for treating fungal infections
|
|
WO2018191692A1
|
|
Methods for treating fungal infections
|
|
WO2018187574A1
|
|
Compositions and methods for the treatment of fungal infections
|
|
WO2018144600A1
|
|
Methods for treating fungal infections
|
|
KR20200047550A
|
|
Prevention and treatment methods of intraperitoneal candidiasis
|
|
WO2018128826A1
|
|
Compositions and methods for the treatment of bacterial infections
|
|
US2021002346A1
|
|
Methods for preventing fungal infections
|
